TCL Archive Why Four? NCI Official Challenged To Explain Rational For Proposed Number Of Groups By Cancer History Project March 25, 2011
TCL Archive Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL By Cancer History Project March 25, 2011
TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate By Cancer History Project March 25, 2011
TCL Archive Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials By Cancer History Project March 25, 2011
TCL Archive XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study By Cancer History Project March 25, 2011
TCL Archive Study Suggests Biomarker For Resistance to Tamoxifen By Cancer History Project March 25, 2011
TCL Archive McCormick President-Elect of AACR; Garber To Start Term As President By Cancer History Project March 25, 2011
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project
